Plan to raise $4 billion! Jingdong health runs IPO
On November 17, yiou.com learned that Jingdong health will launch the IPO in the middle of next week, and plans to ring the bell at the beginning of the second week of December to rush the IPO of blue moon and Evergrande property, which have already passed the hearing. The plan will raise $4 billion, and the exact amount will be determined during the next roadshow.
This text is a result of machine translation.
Briefing Mar 31, 2021 04:41 PM
· Healthcare
Shangtang technology chest X-ray auxiliary diagnosis software has been certified by EU CE
Briefing Mar 24, 2021 05:40 PM
· Healthcare
Cancer cell therapy company raised CNY 500 million in D round
In depth
Healthcare
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Briefing Mar 10, 2021 05:14 PM
· Healthcare
2021 new oxygen emerald list doctors officially assembled to promote the productization of medical and aesthetic consumption decisions
Briefing Mar 01, 2021 11:55 AM
· Healthcare
Baiji Shenzhou PD-1 inhibitor price dropped by 80%
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Dec 09, 2020 08:55 AM
Aug 09, 2020 12:23 AM
Briefing Feb 20, 2021 05:24 PM
· Healthcare
Chuangjian Youming has reached cooperation with many top hospitals in Japan and the United States
Briefing Feb 09, 2021 08:39 AM
· Healthcare
Tens of millions of strategic investment from CommScope
Briefing Feb 08, 2021 04:02 PM
· Healthcare
Beikang medical listed successfully today
Briefing Feb 08, 2021 02:50 PM
· Healthcare
2021 first! Ty batch number of maifute medical total nutrition formula powder
Healthcare
Revenue and Net Profit of Wuxi Apptec Both Increased in 2020
Wuxi apptec said that the main reasons for the company's performance growth were the high growth of laboratories in China and the year-on-year growth of CDMO plate. China laboratory service is the core business of Wuxi apptec, accounting for more than 50% of its revenue. Its main business is small molecule drug discovery, drug analysis and testing.
Apr 01, 2021 04:39 PM
Briefing Feb 07, 2021 06:55 PM
· Healthcare
Deyi sunshine completed tens of millions of Yuan round B financing
Briefing Feb 07, 2021 06:00 PM
· Healthcare
Shenzhi technology completed tens of millions of RMB B + round financing
Briefing Feb 05, 2021 02:07 PM
· Healthcare
Novozyme plus R-CHOP Regimen for first-line treatment of mantle cell lymphoma
Briefing Feb 04, 2021 12:16 PM
· Healthcare
Baiyang pharmaceutical antidepressant duloxetine selected as the fourth batch of national products
Briefing Feb 03, 2021 09:42 AM
· Healthcare
Jingtai technology has signed cooperation with new Geyuan to develop targeted drugs with AI and single cell sequencing as new tumor targets
Briefing Feb 01, 2021 02:41 PM
· Healthcare
Bh009 new drug project independently researched and developed by Beihai biological Co., Ltd. was approved by China's clinical trials
Briefing Feb 01, 2021 10:08 AM
· Healthcare
Novartis health passed the Hong Kong Stock Exchange hearing
See more
Read next
Insight
Technology, Communication
Three Opportunities Brought by Archegos Capital's Outburst
Apr 12, 2021 12:31 PM
Insight
Industrials
Huadi International Group Well Positioned to Recover Quickly Post-COVID
Apr 09, 2021 05:14 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.